IP Library Granted Patent US 7,063,846
Granted Patent B2
US 7,063,846 · App. 10/901,774 · Granted Jun 20, 2006

Outer membrane protein of

Assignee: The Ohio State University Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,063,846
App. No.
10/901,774
Granted
Jun 20, 2006
Kind
B2
Abstract

Diagnostic tools for for serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans are provided. The diagnostic tools are a group of outer membrane proteins of E. chaffeensis and variants thereof, referred to hereinafter as the “OMP proteins”, a group of outer membrane proteins of E. canis and variants thereof referred to hereinafter as the “P30F proteins”, and antibodies to the OMP proteins and the P30F proteins. The OMP proteins of E. chaffeensis encompass OMP-1, OMP-1A, OMP1-B, OMP-1C, OMP1-D, OMP1-E, OMP1-F, OMP1-H, OMP-1R, OMP-1S, OMP-1T, OMP-1U, OMP-1V, OMP-1W, OMP-1X, OMP-1Y and OMP-1Z. The P30F proteins of E. canis encompass P30, P30 a , P30-1, P30-2, P30-3, P30-4, P30-5, P30-6, P30-7, P30-8, P30-9, P30-10, P30-11, and P30-12. Isolated polynucleotides that encode the E. chaffeensis OMP proteins and isolated polynucleotides that encode the E. canis P30F protein are also provided. The present invention also relates to kits containing reagents for diagnosing human ehrlichiosis and canine ehrlichiosis, and to immunogenic compositions containing one or more OMP proteins or P30F proteins.

Claims (21)

1. An isolated or purified antibody that binds to a protein chosen from E. canis protein P30 , E. canis protein P30a, E. canis protein P30-1 , E. canis protein P30-2 , E. canis protein P30-3 , E. canis protein P30-4 , E. canis protein P30-5 , E. canis protein P30-6 , E. canis protein P30-7 , E. canis protein P30-8 , E. canis protein P30-9 , E. canis protein P30-10 , E. canis protein P30-11 , E. canis protein P30-12 , E. chaffeensis protein OMP-1 , E. chaffeensis protein OMP-1A, E. chaffeensis protein OMP-1R, E. chaffeensis protein OMP-1S, E. chaffeensis protein OMP-1T, E. chaffeensis protein OMP-1U, E. chaffeensis protein OMP-1V, E. chaffeensis protein OMP-1W, E. chaffeensis protein OMP-1X, E. chaffeensis protein OMP-1Y, E. chaffeensis protein OMP-1Z, and E. chaffeensis protein OMP-1H.

2. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30 protein.

3. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30a protein.

4. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-1 protein.

5. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-2 protein.

6. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-3 protein.

7. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-4 protein.

8. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-5 protein.

9. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-6 protein.

10. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-7 protein.

11. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-8 protein.

12. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-9 protein.

13. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-10 protein.

14. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-11 protein.

15. The antibody according to claim 1 , wherein the antibody binds to the E. canis P30-12 protein.

16. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1 protein.

17. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1A protein.

18. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1R protein.

19. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1S protein.

20. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1T protein.

21. The antibody according to claim 1 , wherein the antibody binds to the E. chaffeensis OMP-1U protein.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jul 6, 2020
From: TREMONTI CONSULTING
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 053123/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: RIKIHISA, YASUKO; OHASHI, NORIO
To: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 047215/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2018
From: THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 047215/0400 →
CONFIRMATORY LICENSE Recorded Jul 16, 2018
From: OHIO STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046546/0878 →
Continuity (4)
Division 1005996400 · Jan 28, 2002
Division 0931470100 · May 19, 1999
Provisional Application 6010084300 · Sep 18, 1998
Related Publication 20040265334A1 · Dec 30, 2004